Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centromere protein M (CENPM) is a structural inner kinetochore protein that is essential for chromosome segregation during cell division[2][6]. It is a core component of the constitutive centromere-associated network and participates in the assembly and stability of the HIKM complex (with CENP-H, -I, and -K), required for kinetochore function[1][2]. CENPM is structurally related to small GTPases but lacks nucleotide-binding activity[1][2]. Alternative transcription leads to a variant expressed in B-lymphoid cells, with potential immune-regulatory roles[4]. Overexpression of CENPM is implicated in several malignancies and is associated with poor clinical prognosis, supporting its potential as a prognostic biomarker in cancer[3]. As of now, specific drugs targeting CENPM are not clinically established, but its biological significance in mitosis and oncogenesis supports ongoing research interest in its mechanistic and therapeutic potential[3].
Not established as a direct therapeutic target for small molecules or biologics; proposed mechanisms in cancer models include modulation of cell proliferation and apoptosis via regulation of the AKT/mTOR signaling pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centromere protein M (CENPM).